Allergic diseases are chronic inflammatory conditions, characterised by eosinophil inflammation systemically and in target organs, where cytotoxic granule proteins are responsible for tissue injury.
Kämpe, Mary
core
Evaluating the efficacy and safety of Stapokibart (CM310) in the treatment of uncontrolled seasonal allergic rhinitis based on real-world research. [PDF]
Chen J, Lu K, Tang P, Liu Y, Huang D.
europepmc +1 more source
Prospective, Single-Arm, Investigator-Initiated Study to Evaluate Efficacy and Safety of Levocetirizine Hydrochloride 5 mg and Montelukast 10 mg (L-Montus) in Patients With Seasonal Allergic Rhinitis and Perennial Allergic Rhinitis. [PDF]
Ramappa C +6 more
europepmc +1 more source
Chinese Position Paper on Biologic Therapy for Allergic Rhinitis. [PDF]
Zhang Y +37 more
europepmc +1 more source
Efficacy and safety of a particulate yeast β-glucan preparation in the treatment of seasonal allergic rhinitis (BETALL): a randomised placebo-controlled crossover trial protocol. [PDF]
Briskey D +5 more
europepmc +1 more source
Clinical observation of stapokibart in patients under 18 years of age with seasonal allergic rhinitis: a case series study of 20 cases. [PDF]
Wang LF, Ma WC, Kan CX, Hao GD.
europepmc +1 more source
Thunderstorm-Associated Asthma in Shenzhen, China: A Retrospective Case-Control Study of Risk Factors, Clinical Characteristics, and Management Approaches. [PDF]
Shang X, Yang Y, Deng W.
europepmc +1 more source
Emerging perspectives in respiratory allergic diseases: a review of future directions. [PDF]
Durán R +5 more
europepmc +1 more source

